These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11349630)

  • 21. Inflammation in atherosclerosis and implications for therapy.
    Paoletti R; Gotto AM; Hajjar DP
    Circulation; 2004 Jun; 109(23 Suppl 1):III20-6. PubMed ID: 15198962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chlamydial and human heat shock protein 60 homologues in acute coronary syndromes. (Auto-)immune reactions as a link between infection and atherosclerosis].
    Andrié R; Braun P; Welsch U; Straube E; Höpp HW; Erdmann E; Lüderitz B; Bauriedel G
    Z Kardiol; 2003 Jun; 92(6):455-65. PubMed ID: 12819994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomegalovirus, Chlamydia pneumoniae, and Helicobacter pylori IgG antibodies and restenosis after stent implantation: an angiographic and intravascular ultrasound study.
    Schiele F; Batur MK; Seronde MF; Meneveau N; Sewoke P; Bassignot A; Couetdic G; Caulfield F; Bassand JP
    Heart; 2001 Mar; 85(3):304-11. PubMed ID: 11179272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Persistence of Chlamydia pneumoniae in coronary plaque tissue. A contribution to infection and immune hypothesis in unstable angina pectoris].
    Bauriedel G; Andrié R; Likungu JA; Welz A; Braun P; Welsch U; Lüderitz B
    Dtsch Med Wochenschr; 1999 Nov; 124(47):1408-13. PubMed ID: 10605420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum chlamydial lipopolysaccharide as a prognostic factor for a new cardiovascular event.
    Pesonen E; Tiirola T; Andsberg E; Jauhiainen M; Paldanius M; Persson K; Saikku P; Sarna S; Ohlin H; Leinonen M
    Heart Lung; 2009; 38(3):176-81. PubMed ID: 19486785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age.
    Gattone M; Iacoviello L; Colombo M; Castelnuovo AD; Soffiantino F; Gramoni A; Picco D; Benedetta M; Giannuzzi P
    Am Heart J; 2001 Oct; 142(4):633-40. PubMed ID: 11579353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Markers of inflammatory process in stable and unstable coronary artery disease].
    Okopień B; Basiak M; Madej A; Labuzek K; Belowski D; Haberka M; Herman ZS
    Pol Merkur Lekarski; 2006 Jul; 21(121):69-72. PubMed ID: 17007298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease.
    Al-Ghamdi A; Jiman-Fatani AA; El-Banna H
    Pak J Pharm Sci; 2011 Apr; 24(2):95-101. PubMed ID: 21454155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
    Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
    Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic infection and coronary artery disease.
    Muhlestein JB
    Med Clin North Am; 2000 Jan; 84(1):123-48. PubMed ID: 10685131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction.
    Anderson JL; Carlquist JF; Muhlestein JB; Horne BD; Elmer SP
    J Am Coll Cardiol; 1998 Jul; 32(1):35-41. PubMed ID: 9669246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.
    Anderson JL; Muhlestein JB; Carlquist J; Allen A; Trehan S; Nielson C; Hall S; Brady J; Egger M; Horne B; Lim T
    Circulation; 1999 Mar; 99(12):1540-7. PubMed ID: 10096928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease.
    Mehta JL; Saldeen TG; Rand K
    J Am Coll Cardiol; 1998 May; 31(6):1217-25. PubMed ID: 9581711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study.
    Hillis GS; Pearson CV; Harding SA; Sutherland S; Ludlam CA; Marioni JC; Prescott RJ; Fox KA; Flapan AD
    Am Heart J; 2004 Jul; 148(1):72-9. PubMed ID: 15215794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of infection and inflammation markers for late cardiac events in an Iranian sample.
    Sarrafzadegan N; Rezaporian P; Kaypour M; Mohseni M; Sadeghi M; Asgary S; Sabet B
    East Mediterr Health J; 2008; 14(6):1246-56. PubMed ID: 19161100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parameters of inflammation and infection in a community based case-control study of coronary heart disease.
    De Backer J; Mak R; De Bacquer D; Van Renterghem L; Verbraekel E; Kornitzer M; De Backer G
    Atherosclerosis; 2002 Feb; 160(2):457-63. PubMed ID: 11849671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-reactive protein, Helicobacter pylori, Chlamydia pneumoniae, cytomegalovirus and risk for myocardial infarction.
    Witherell HL; Smith KL; Friedman GD; Ley C; Thom DH; Orentreich N; Vogelman JH; Parsonnet J
    Ann Epidemiol; 2003 Mar; 13(3):170-7. PubMed ID: 12604160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial.
    Westerhout CM; Gnarpe J; Chang WC; FitzPatrick S; Barnathan ES; Boersma E; Califf RM; Wallentin L; Simoons ML; Armstrong PW;
    Am Heart J; 2007 Aug; 154(2):306-12. PubMed ID: 17643581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute-phase response of human hepatocytes after infection with Chlamydia pneumoniae and cytomegalovirus.
    Verkerk MS; Visseren FL; Paul Bouter K; Diepersloot RJ
    Eur J Clin Invest; 2003 Aug; 33(8):720-5. PubMed ID: 12864783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase of chlamydial LPS antibodies in patients with acute coronary syndrome without detection of chlamydial DNA in atherectomy samples.
    Kiss K; Khanakah G; Kundi M; Glogar HD; Stanek G
    Wien Klin Wochenschr; 2001 Oct; 113(19):731-6. PubMed ID: 11715751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.